<DOC>
	<DOCNO>NCT03003104</DOCNO>
	<brief_summary>The study evaluate safety , tolerability , efficacy DMT210 Gel , 5 % applied twice daily 12 week adult patient moderate severe acne rosacea . Half participant receive DMT210 Gel half receive vehicle control .</brief_summary>
	<brief_title>DMT210 Topical Gel Treatment Acne Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<criteria>Patient male nonpregnant female least 18 year age . Clinical diagnosis moderate severe facial rosacea determine Investigator 's Global Assessment ( IGA ) Randomization Patient least ten inflammatory lesion rosacea face Randomization Patient willing apply Investigational Product direct Patient willing able comply protocol Patient pregnant planning become pregnant Patient take topical therapy may affect patient 's rosacea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Skin disease</keyword>
	<keyword>rosacea</keyword>
</DOC>